Overview

Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer

Status:
Terminated
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the objective response rate when ZARNESTRA is added to treatment with tamoxifen
Phase:
Phase 2
Details
Lead Sponsor:
Institut Claudius Regaud
Collaborator:
Janssen-Cilag Ltd.
Treatments:
Estrogens
Progesterone
Tamoxifen
Tipifarnib